search

Active clinical trials for "Lung Neoplasms"

Results 1571-1580 of 6521

Pulmonary Rehabılıtatıon Wıth Non-Small Lung Cancer

Lung CancerLung Cancer1 more

The aim of our study is to investigate the effects of pulmonary rehabilitation on respiratory tests and quality of life in patients with early and locally advanced NSCLC who received chemotherapy regardless of whether the investigators had undergone surgical treatment.

Not yet recruiting6 enrollment criteria

Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy...

Lung Neoplasm Malignant

It is important for clinicians to maintain and support for exercise capacity and quality of life of lung cancer patients after radiation therapy, because radiation therapy also affect the lung function and general conditions of patients. The effect and safety of pulmonary rehabilitation is well-proven in various diseases. Because there is no standard treatment, the investigators will perform this study to clearly prove the effect of pulmonary rehabilitation in lung cancer patients receiving radiation therapy.

Not yet recruiting7 enrollment criteria

A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung...

Advanced Lung Cancer

A non-randomized, open, Simon'soptimal2-stage study to evaluate the efficacy and safety of 6MW3211 in patients with advanced Lung Cancer who had failed therapy with PD-1/L1 Inhibitor.

Not yet recruiting29 enrollment criteria

EZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer...

Non Small Cell Lung Cancer

This is an open label, single arm, phase Ib/II clinical trial of checkpoint blockade, pembrolizumab and EZH2 inhibitor, tazemetostat combination therapy for patients with advanced non-small cell lung cancer who have progressed from front or second-line treatment. Patients will be enrolled at multiple Veterans Affairs Medical Centers.

Not yet recruiting47 enrollment criteria

The Effects of Chronic Stress on the Occurrence, Development and Prognosis of Lung Cancer Patients...

Lung CancerChronic Stress Disorder1 more

Chronic stress is the response of the body to physiological and psychological stressors and manifests as depression and anxiety symptoms, which are common among cancer patients. It was reported that chronic stress could contribute to a highly immunosuppressive tumor microenvironment and undermine the efficacy of immune checkpoint inhibitors (ICIs) in preclinical studies. Therefore, we investigate the impact of chronic stress on the efficacy of ICIs among lung cancer patients.

Recruiting17 enrollment criteria

Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation...

Lung Cancer

Motive: In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from lung cancer patients. Goal: To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life. A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

Recruiting3 enrollment criteria

The Effect of Beta-glucan in Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

The purpose of this study is to determine how beta-glucan affects the immune system in subjects with non-small cell lung cancer.

Recruiting21 enrollment criteria

A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment...

Non-small Cell Lung Cancer (NSCLC)EGFR-TKI Resistant Mutation3 more

For patients of advanced NSCLC (non small cell lung cancer) , Individualized cancer therapy has been widely accepted since the success of crizotinib administration based on EML4-ALK fusion gene detection and gefitinib and erlotinib administration based on EGFR-TKIs sensitive mutations.From clinical points of view ,individual differences often occur between different patients, leading diverse effect in ADR and drug effect.Meanwhile ,the drug effect and adverse drug reaction was significantly influenced by the pharmacokinetic factors and pharmacodynamic factors.In this research ,we try to establish a more sensitive method to detect sensitive mutations in plasma and discover the correlation between somatic and germline mutations , trough concentration and EGFR-TKI drug effect, the association between ADME-associated SNP ,trough concentration and EGFR-TKI adverse effect .Furthermore, in vivo and in vitro research is also crucial for rational explanation for these clinical phenomenon.

Recruiting2 enrollment criteria

Personalized Sequence for Thoracic, Esophageal, and H&N Cancer

Lung Cancer

The next generation of personalized medical treatment according to the type of personal genetic information are evolving rapidly. The genome analysis needs systematic infra and database based on personal genetic information Therefore, a big data of genome-clinical information is important.

Recruiting2 enrollment criteria

Circulating Tumor Cells (CTC) in Lung Cancer

Lung Neoplasms

The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).

Recruiting6 enrollment criteria
1...157158159...653

Need Help? Contact our team!


We'll reach out to this number within 24 hrs